50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,655.04
DOW   29,260.81
QQQ   274.37
This Device Makes Creating Voice Memos Easy
Sell every Stock except ONE (Ad)
Three Consumer Stocks That Could Outperform In Q4 
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
Sell every Stock except ONE (Ad)
Comcast is an Asset Bonanza Priced Cheap
US stocks slip deeper into a slump as recession fears grow
Sell every Stock except ONE (Ad)
British pound plunges to new low as tax cuts spark concern
Lights out, ovens off: Europe preps for winter energy crisis
S&P 500   3,655.04
DOW   29,260.81
QQQ   274.37
This Device Makes Creating Voice Memos Easy
Sell every Stock except ONE (Ad)
Three Consumer Stocks That Could Outperform In Q4 
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
Sell every Stock except ONE (Ad)
Comcast is an Asset Bonanza Priced Cheap
US stocks slip deeper into a slump as recession fears grow
Sell every Stock except ONE (Ad)
British pound plunges to new low as tax cuts spark concern
Lights out, ovens off: Europe preps for winter energy crisis
S&P 500   3,655.04
DOW   29,260.81
QQQ   274.37
This Device Makes Creating Voice Memos Easy
Sell every Stock except ONE (Ad)
Three Consumer Stocks That Could Outperform In Q4 
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
Sell every Stock except ONE (Ad)
Comcast is an Asset Bonanza Priced Cheap
US stocks slip deeper into a slump as recession fears grow
Sell every Stock except ONE (Ad)
British pound plunges to new low as tax cuts spark concern
Lights out, ovens off: Europe preps for winter energy crisis
S&P 500   3,655.04
DOW   29,260.81
QQQ   274.37
This Device Makes Creating Voice Memos Easy
Sell every Stock except ONE (Ad)
Three Consumer Stocks That Could Outperform In Q4 
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
Sell every Stock except ONE (Ad)
Comcast is an Asset Bonanza Priced Cheap
US stocks slip deeper into a slump as recession fears grow
Sell every Stock except ONE (Ad)
British pound plunges to new low as tax cuts spark concern
Lights out, ovens off: Europe preps for winter energy crisis
NYSE:NTR

Nutrien - NTR Earnings Date, Estimates & Call Transcripts

$81.75
-1.19 (-1.43%)
(As of 09/26/2022 12:00 AM ET)
Add
Compare
Today's Range
$81.65
$84.68
50-Day Range
$78.32
$101.69
52-Week Range
$64.34
$117.25
Volume
1.97 million shs
Average Volume
3.42 million shs
Market Capitalization
$44.09 billion
P/E Ratio
6.61
Dividend Yield
2.31%
Price Target
$108.75

Earnings Summary

Upcoming
Earnings Date
Nov. 7Estimated
Actual EPS
(Aug. 3)
$5.85 Missed By -$0.05
Consensus EPS
(Aug. 3)
$5.90
Last Year's Q3 EPS
(8/9/2021)
$2.08
Skip Charts & View Estimated and Actual Earnings Data

NTR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NTR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Nutrien Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20223$2.49$2.83$2.64 
Q2 20223$4.41$5.66$5.18 
Q3 20223$3.16$4.97$4.21 
Q4 20223$3.20$3.99$3.72 
FY 202212$13.26$17.45$15.75 
Q1 20232$2.65$4.21$3.43 
Q2 20232$4.78$6.21$5.50 
Q3 20232$2.71$3.87$3.29 
Q4 20232$3.04$3.72$3.38 
FY 20238$13.18$18.01 $15.60

NTR Earnings Date and Information

Nutrien last issued its quarterly earnings data on August 3rd, 2022. The reported $5.85 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.90 by $0.05. The company had revenue of $14.51 billion for the quarter, compared to the consensus estimate of $15.36 billion. Nutrien has generated $12.36 earnings per share over the last year ($12.36 diluted earnings per share) and currently has a price-to-earnings ratio of 6.6. Earnings for Nutrien are expected to decrease by -7.03% in the coming year, from $16.35 to $15.20 per share. Nutrien has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 7th, 2022 based off prior year's report dates.

Nutrien Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/7/2022
(Estimated)
        
8/3/2022Q2 2022$5.90$5.85($0.05)$5.19$15.36 billion$14.51 billion
5/2/2022Q1 2022$2.59$2.70+$0.11$2.91$7.77 billion$7.66 billion    
2/16/2022Q4 2021$2.30$2.47+$0.17$2.83$6.53 billion$7.07 billion    
11/1/20219/30/2021$1.23$1.38+$0.15$1.51$5.59 billion$6.02 billion    
8/9/20216/30/2021$2.10$2.08($0.02)$2.22$9.65 billion$9.76 billion    
5/2/20213/31/2021$0.09$0.29+$0.20$0.36$4.37 billion$4.66 billion  
2/17/202112/31/2020$0.15$0.24+$0.09($0.07)$3.58 billion$4.05 billion  
11/2/20209/30/2020$0.07$0.23+$0.16$1.49$3.83 billion$4.21 billion  
8/10/20206/30/2020$1.37$1.45+$0.08$1.56$8.32 billion$8.42 billion  
5/6/20203/31/2020($0.04)($0.12)($0.08)($0.18)$3.44 billion$4.19 billion  
2/18/202012/31/2019$0.28$0.09($0.19)$0.26$3.36 billion$3.44 billion  
11/4/20199/30/2019$0.36$0.24($0.12)$0.30$4.02 billion$4.13 billion  
7/29/20196/30/2019$1.59$1.58($0.01)$1.69$8.17 billion$8.66 billion
5/9/2019Q1$0.24$0.20($0.04)$0.33$3.71 billion$3.69 billion
2/6/201912/31/2018$0.54$0.54($4.14)$3.61 billion$3.76 billion
11/5/20189/30/2018$0.44$0.47+$0.03$2.64$3.83 billion$4.03 billion
8/1/20186/30/2018$1.40$1.48+$0.08$0.72$7.70 billion$8.15 billion
5/7/2018Q1$0.17$0.16($0.01)$0.32$3.87 billion$3.70 billion
10/26/2017Q3 2017$0.30$0.23($0.07)$0.31$1.01 billion$1.06 billion
7/27/2017Q2 2017$0.43$0.40($0.03)$0.20$935.92 million$1.00 billion
4/27/2017Q1 2017$0.25$0.45+$0.20$0.45$927.90 million$979.00 million
1/26/2017Q4 2016$0.23$0.18($0.05)$0.18$1.03 billion$928.00 million
10/27/2016Q3 2016$0.23$0.28+$0.05$0.31$1.00 billion$982.00 million
7/28/2016Q2 2016$0.45$0.45$0.55$1.14 billion$935.00 million
4/28/2016Q1 2016$0.40$0.38($0.02)$0.53$1.25 billion$1.08 billion
1/28/2016Q4 2015$0.75$0.60($0.15)$0.60$1.49 billion$1.25 billion
10/29/2015Q3 2015$0.95$0.85($0.10)$0.85$1.49 billion$1.40 billion
7/30/2015Q2 2015$1.30$1.25($0.05)$1.25$1.72 billion$1.73 billion
4/30/2015Q1 2015$1.25$1.10($0.15)$1.10$1.70 billion$1.67 billion
1/29/2015Q4 2014$1.15$1.23+$0.08$1.23$1.66 billion$1.90 billion
10/23/2014Q3 2014$1.05$0.95($0.10)$0.95$1.49 billion$1.50 billion
7/24/2014Q2 2014$1.10$1.40+$0.30$1.40$1.67 billion$1.89 billion
4/24/2014Q1 2014$0.88$0.95+$0.07$0.90$1.55 billion$1.68 billion
1/30/2014Q4 2013$0.83$0.78($0.05)$0.91$1.39 billion$1.54 billion
10/24/2013Q3 2013$1.03$1.03$1.03$1.55 billion$1.52 billion
7/25/2013Q2 2013$2.05$1.83($0.22)$1.83$2.23 billion$2.14 billion
4/25/2013Q1 2013$1.53$1.58+$0.05$1.58$1.92 billion$2.10 billion
1/31/2013Q4 2012$1.48$1.30($0.18)$1.40
10/25/2012Q3 2012$1.83$1.85+$0.02$1.85
7/26/2012Q2 2012$2.55$2.53($0.02)$3.56
4/26/2012Q1 2012$1.63$1.40($0.23)$1.40
1/26/2012Q4 2011$2.23$1.95($0.28)$1.95
10/27/2011Q3 2011$2.33$2.36+$0.03$2.36
7/28/2011Q2 2011$2.15$2.40+$0.25$2.40
4/28/2011Q1 2011$2.00$2.10+$0.10$2.10
1/27/2011Q4 2010$1.37$1.48+$0.11$1.62
10/28/2010Q3 2010$0.96$1.10+$0.14$1.10
7/29/2010Q2 2010$1.02$1.29+$0.27$1.29
4/29/2010Q1 2010$1.16$1.23+$0.07$1.23
1/28/2010Q4 2009$0.67$0.67$0.67
10/22/2009Q3 2009$0.68$0.68$0.68
7/23/2009Q2 2009$0.60$0.52($0.08)$0.52
4/22/2009Q1 2009$0.70$0.85+$0.15$0.85
1/22/2009Q4 2008$1.91$2.13+$0.22$2.13
10/23/2008Q3 2008$2.96$3.28+$0.32$3.28
7/24/2008Q2 2008$2.13$2.35+$0.22$2.35
4/24/2008Q1 2008$1.25$1.45+$0.20$1.45
1/24/2008Q4 2007$0.83$0.97+$0.14$0.97












Nutrien Earnings - Frequently Asked Questions

When is Nutrien's earnings date?

Nutrien has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 7th, 2022 based off last year's report dates. Learn more on NTR's earnings history.

Did Nutrien beat their earnings estimates last quarter?

In the previous quarter, Nutrien (NYSE:NTR) missed the analysts' consensus estimate of $5.90 by $0.05 with a reported earnings per share (EPS) of $5.85. Learn more on analysts' earnings estimate vs. NTR's actual earnings.

How much revenue does Nutrien generate each year?

Nutrien (NYSE:NTR) has a recorded annual revenue of $27.71 billion.

How much profit does Nutrien generate each year?

Nutrien (NYSE:NTR) has a recorded net income of $3.15 billion. NTR has generated $12.36 earnings per share over the last four quarters.

What is Nutrien's price-to-earnings ratio?

Nutrien (NYSE:NTR) has a trailing price-to-earnings ratio of 6.61 and a forward price-to-earnings ratio of 5.00. The price/earnings-to-growth ratio is 0.63.

What is Nutrien's EPS forecast for next year?

Nutrien's earnings are expected to decrease from $16.35 per share to $15.20 per share in the next year, which is a -7.03% change.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NYSE:NTR) was last updated on 9/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.